What is the recommended evaluation and management plan for a person suspected of being on the autism spectrum?

Evaluation and Management of Suspected Autism Spectrum Disorder

All persons suspected of having autism spectrum disorder should receive formal diagnostic confirmation by a trained professional using objective criteria, followed immediately by genetic consultation and structured behavioral interventions, as genetic testing now yields diagnostic results in 30-40% of cases and early intervention significantly improves outcomes 1.

Initial Diagnostic Confirmation

Before proceeding with any evaluation, confirm the ASD diagnosis using:

• Formal assessment by a professional trained in autism diagnosis using standardized, objective tools 1
• Complete audiogram to rule out hearing loss as a primary cause 1, 2, 1
• Cognitive and adaptive skills testing to establish baseline functioning and identify areas of strength/weakness 3
• Communication assessment measuring both receptive/expressive language and pragmatic language use 3

Critical pitfall: Many neurodevelopmental disorders have overlapping phenotypes with ASD. Do not initiate genetic workup or interventions without confirmed diagnosis 2.

Establish Primary Care Medical Home

Every individual with confirmed ASD requires a designated primary care physician who will:

• Coordinate all diagnostic testing and referrals 1
• Partner with clinical geneticist in ordering and scheduling tests 1
• Monitor for co-occurring medical conditions affecting function and quality of life 4

Genetic Evaluation (Mandatory Referral)

Offer genetic consultation to ALL persons with ASD regardless of where they fall on the spectrum 1. The diagnostic yield has increased dramatically from 6-10% to 30-40% with modern testing 1.

Tiered Genetic Testing Approach

First Tier (highest yield, perform first):

• High-resolution chromosomal analysis (karyotype) 2
• Fragile X DNA testing 2
• Chromosomal microarray (comparative genomic hybridization) - now elevated to first-tier due to improved technology 1
• Physical examination focusing on dysmorphic features with Wood's lamp evaluation 2

Second Tier (if first tier negative):

• MECP2 gene testing (females only) 2
• PTEN gene testing (if head circumference >2.5 SD above mean) 2
• Fibroblast karyotype if clonal pigmentary abnormalities noted 2

Additional testing only if clinical indicators present:

• EEG if seizure history or staring spells 2, 3
• Metabolic screening if clinical suspicion and not covered by newborn screening 2
• Brain MRI for specific clinical indications 2

Genetic Counseling (Essential Component)

Provide counseling to all families regardless of whether etiology is identified 1:

If no etiology identified, use empiric recurrence risk data:

• 7% risk if affected child is female
• 4% risk if affected child is male
• 30% risk if two or more children already affected 1

Periodic re-evaluation: Schedule follow-up consultations as technology and phenotype understanding evolves - many initially undiagnosed cases eventually receive diagnosis 1.

Screen for Medical Contributors to Symptoms

Systematically evaluate conditions that affect function and quality of life 5, 4:

Sleep disorders (insomnia is extremely common):

• Ask specific questions: "Does your child have difficulty falling asleep?" and "Does your child awaken during the night?" 5
• Parents often don't volunteer sleep concerns due to focus on behavioral issues 5

Gastrointestinal symptoms 5

Seizures/epilepsy 5

Pain conditions 5

Psychiatric comorbidities: anxiety, depression, bipolar disorder 5

Medication review: many medications contribute to symptoms 5

Immediate Intervention Referral

Do not wait for genetic results - refer immediately for intervention upon diagnostic confirmation 6.

First-Line Treatment: Behavioral/Educational Interventions

Educational and behavioral interventions are first-line treatment after excluding medical contributors 5. These are prioritized because:

• Children with ASD may not express medication adverse effects 5
• Evidence supports efficacy for improving outcomes 3
• Core ASD deficits (difficulty with emotional regulation, transitioning, communication) respond to structured approaches 5

Specific behavioral approaches with evidence:

• Applied Behavioral Analysis (ABA) using learning principles 3
• Early Intensive Behavioral Intervention (up to 40 hours/week for young children) 3
• Structured bedtime routines with visual supports for sleep issues 5

When behavioral approaches may not be feasible:

• Family in crisis state 5
• Severe daytime behavioral challenges 5
• Financial constraints preventing implementation 5
• Insufficient practitioner instruction available 5

In these situations, consider pharmacologic treatment while continuing to work toward behavioral implementation 5.

Functional Analysis for Maladaptive Behaviors

When behaviors interfere with comprehensive intervention, conduct functional analysis of target behaviors before implementing behavioral techniques 3.

Ongoing Monitoring

Schedule periodic re-evaluations because:

• Technology advances may enable diagnosis in previously undiagnosed cases 1
• Phenotypes evolve with development 1
• Co-occurring conditions emerge over time 4

Coordinate care between primary care physician and clinical geneticist for management plans specific to any identified etiology 1.

Special Consideration: Siblings

Siblings of children with ASD require intensified surveillance with ASD-specific screening at 18 and 24 months minimum, as recurrence risk is 14-18% (substantially higher than population risk) 6.